Search
for
Sort by
Research 31–60 of 357
- Teriflunomide in multiple sclerosis: an update
- Hair Changes due to Drugs
- Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
- Structure-guided PEGylated fibroblast growth factor 2 variants accelerate wound healing with improved stability
- Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process
- Gene therapy to enhance angiogenesis in chronic wounds
- Photo-Responsive Ascorbic Acid-Modified Ag<sub>2</sub>S–ZnS Heteronanostructure Dropping pH to Trigger Synergistic Antibacterial and Bohr Effects for Accelerating Infected Wound Healing
- CUTANEOUS T-CELL LYMPHOMA
- Contaminants of emerging concern in the fetal environment
- Aldesleukin
- Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens
- Life Sciences Discovery and Technology Highlights
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Efluvio anágeno. Hallazgos tricoscópicos
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Dermatologic Adverse Events from Cancer Treatments
- Aromatic plants as cosmeceuticals: benefits and applications for skin health
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls
- Ocular Cosmetics in Modern Times
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Diseases of Periocular Hair
- Cutaneous Reactions to Drugs
- Cutaneous drug reactions
- Dermatolojik Problemler ve COVID-19
- Alopecias
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Alopecia in patients treated with molecularly targeted anticancer therapies